Table 3 General characteristics of survivors and non-survivors

Age, months

24 (8–69)

18 (6–60)

0.45

Male sex

87 (47.8%)

22 (56.4%)

0.33

Weight, kg

11 (6–17.5)

8.5 (6–20)

0.37

Body mass index

15.8 (14.2–18.2)

14.9 (13–17.7)

0.14

Malnutrition

48 (26.4%)

17 (43.6%)

0.032^*

Complex chronic conditions

84 (46.2%)

20 (51.3%)

0.56

Sepsis

58 (40.8%)

14 (35.9%)

0.71

pSOFA^a

5 (4–6)

8 (6–10)

<0.001^*

ARDS^b

0 (0%)

5 (12.8%)

<0.001^*

Mechanical ventilation

39 (21.4%)

37 (94.9%)

<0.001^*

Mechanical ventilation duration, days

0 (0–0)

6 (3–23)

<0.001^*

Vasoactive medications

36 (19.8%)

25 (64.1%)

<0.001^*

Vasoactive infusion days

0 (0–0)

3 (0–8)

<0.001^*

Central venous catheter days

0 (0–8)

22 (5.5–43)

<0.001^*

Hospital-acquired infections

43 (23.6%)

25 (64.1%)

<0.001^*

 VAP^c

3 (1.6%)

6 (15.4%)

0.064

 CLABSI^d

28 (15.4%)

14 (35.9%)

 VAP+CLABSI^**

3 (1.6%)

3 (7.7%)

 Others^***

9 (4.9%)

1 (2.6%)

PICU^estay, days

8 (4–13)

13 (6–36)

0.002^*

WBC^f, 1000/μL

12.8 (8.9–18)

10.1 (7.2–16.4)

0.11

Hemoglobin, g/dL

10.5 (9.1–11.7)

10.0 (9.5–12.2)

0.68

Platelets, 1000/μL

297.5 (203.8–409)

241 (128–361)

0.033^*

CRP^g, mg/dL

9.9 (3–48)

24 (12- 80)

0.023^*

Creatinine, mg/dL

0.4 (0.3–0.6)

0.5 (0.4–0.7)

0.13

ALT^h, U/L

20 (12–38)

41 (21–130)

<0.001^*